FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

GOP Senator Does Deep Dive on Trump Assassination Attempt and Remains Troubled by ‘Unresolved’ Questions

DHS unloads on anti-ICE Dems after man arrested with manifesto, ‘disturbing’ alleged plot to kill agents

Grand Jury Delivers Decision on Indictments for Democrats Known as the ‘Seditious Six’

Hispanic conservatives accuse House GOP hopeful of defrauding donors and activists

McConnell released from hospital after health scare, to work from home as key DHS vote looms

Democrats rip Bondi over handling of Epstein case in rowdy House hearing

Bondi has tense exchanges with lawmakers in first House hearing since confirmation

Exclusive: FBI captures longtime fugitive in Honduras in connection with 2000 killing of Philadelphia girl

Retail records could unmask potential subject in Nancy Guthrie case as experts reveal ‘clothing is evidence’

Trump Religious Liberty Commission boots member after contentious antisemitism hearing

Hardline conservatives double down to save the SAVE Act

Trump Keeps Winning: President Takes Victory Lap After Latest Job Numbers Shatter Expectations

Indicted Dem Rep. LaMonica McIver Suggests Acting ICE Director Is Doomed to Hell as Hearing Spirals Out of Control

ICE director refuses to resign under pressure from Eric Swalwell not to ‘side with killers’

Tillis rips ‘political lawfare’ and praises grand jury after Dems avoid charges in ‘illegal orders’ case

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”